← Back to Search

Mattress

P500 Mattress for Pressure Sores

N/A
Waitlist Available
Led By Joyce Black, PhD, RN
Research Sponsored by Hill-Rom
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of study period (21 days)
Awards & highlights

Summary

This pilot study will compare the incidence of pressure ulcers and the change in existing pressure ulcers for patients who are either placed on the new TC500 bed against those placed on the standard ICU bed in the Cardiovascular unit of University of Nebraska Medical Center. Additionally, the cost associated with rental beds will be calculated as well as skin care compliance. Sixty patients will be enrolled (30 per study arm).

Eligible Conditions
  • Pressure Sores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Indicence of Pressure Ulcers
Secondary outcome measures
Cost of Rental Beds

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: P500 MattressExperimental Treatment1 Intervention
The new P500 Low Air Loss mattress will be used to replace the standard mattress for this study arm.
Group II: Standard of Care MattressActive Control1 Intervention
Cardiovascular ICU patients that receive standard of care mattress (Total Care Treatment Mattress) and standard pressure ulcer prevention care. All patients had daily skin assessments, as per normal care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P500 Mattress
2008
N/A
~60

Find a Location

Who is running the clinical trial?

Hill-RomLead Sponsor
33 Previous Clinical Trials
2,790 Total Patients Enrolled
Joyce Black, PhD, RNPrincipal InvestigatorUniversity of Nebraska
1 Previous Clinical Trials
12 Total Patients Enrolled
~3 spots leftby Sep 2025